Fresh Tracks Therapeutics, Inc.
FRTX · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | -$0 | -$0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 15.3% | 1,618.6% | -77.8% | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | 100% | -102.3% | -6,887.9% | -515.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -70.5% | -303.4% | -9,748.3% | -1,147.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -71.1% | -297.6% | -9,782.4% | -1,147.3% |
| EPS Diluted | -0.96 | -7.36 | -22.14 | -38.37 |
| % Growth | 87% | 66.8% | 42.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |